Published :
Tables : 47
Figures : 43
Category : Healthcare
No. of Pages : 227
Report Code : HC-U4442
Europe Viral Inactivation Market Overview: FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe Viral Inactivation Market trend that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Europe Viral Inactivation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Europe Viral Inactivation Market: • Clean Cells • Charles River Laboratories International, Inc. • Danaher Corporation • Merck KGaA • Parker Hannifin • Rad Source Technologies • Sartorius AG • SGS S.A. • Texcell, Inc. • Viral Inactivated Plasma Systems SA (Note: The list of the major players will be updated with the latest market scenario and trends) Europe Viral Inactivation Market Segmentation: By Product Type • Kits and Reagents • Services • Accessories By Application • Blood & Blood Products • Cellular & Gene Therapy Products • Stem Cell Products • Tissue & Tissue Products • Vaccines and Therapeutics By Method • Solvent Detergent Method • Pasteurization • Other Viral Inactivation Method By Region • Germany • U.K • France • Italy • Spain • Russia • Poland • Rest of Europe Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Europe Viral Inactivation Market By Product Type, By Application, By Method and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Germany, U.K, France, Italy, Spain, Russia, Poland, Rest of Europe • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customisation offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe Viral Inactivation Market trend that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Europe Viral Inactivation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Europe Viral Inactivation Market: • Clean Cells • Charles River Laboratories International, Inc. • Danaher Corporation • Merck KGaA • Parker Hannifin • Rad Source Technologies • Sartorius AG • SGS S.A. • Texcell, Inc. • Viral Inactivated Plasma Systems SA (Note: The list of the major players will be updated with the latest market scenario and trends) Europe Viral Inactivation Market Segmentation: By Product Type • Kits and Reagents • Services • Accessories By Application • Blood & Blood Products • Cellular & Gene Therapy Products • Stem Cell Products • Tissue & Tissue Products • Vaccines and Therapeutics By Method • Solvent Detergent Method • Pasteurization • Other Viral Inactivation Method By Region • Germany • U.K • France • Italy • Spain • Russia • Poland • Rest of Europe Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Europe Viral Inactivation Market By Product Type, By Application, By Method and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Germany, U.K, France, Italy, Spain, Russia, Poland, Rest of Europe • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customisation offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Europe Viral Inactivation Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Product Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Europe Viral Inactivation Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Product Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Product Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Europe Viral Inactivation Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Kits and Reagents 7.2. Services 7.3. Accessories 8. Europe Viral Inactivation Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Blood & Blood Products 8.2. Cellular & Gene Therapy Products 8.3. Stem Cell Products 8.4. Tissue & Tissue Products 8.5. Vaccines and Therapeutics 9. Europe Viral Inactivation Market, by Method Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Solvent Detergent Method 9.2. Pasteurization 9.3. Other Viral Inactivation Method 10. Europe Viral Inactivation Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.8. Rest of Europe 10.3. Market Size (USD Million) Forecast for Europe 2020-2027 11. Market Share Analysis and Competitive Landscape 11.1. Europe Landscape - Key Players, Revenue and Presence 11.2. Europe Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 11.3. Europe Emerging Companies 11.4. Europe - Market Share Analysis and Key Regional Players 11.5. Europe Key Player - Growth Matrix 12. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 12.1. Clean Cells 12.1.1. Company Overview 12.1.2. Product Portfolio 12.1.3. SWOT Analysis 12.1.4. Financial Overview 12.1.5. Strategic Overview 12.2.Charles River Laboratories International, Inc. 12.2.1. Company Overview 12.2.2. Product Portfolio 12.2.3. SWOT Analysis 12.2.4. Financial Overview 12.2.5. Strategic Overview 12.3.Danaher Corporation 12.3.1. Company Overview 12.3.2. Product Portfolio 12.3.3. SWOT Analysis 12.3.4. Financial Overview 12.3.5. Strategic Overview 12.4. Merck KGaA 12.4.1. Company Overview 12.4.2. Product Portfolio 12.4.3. SWOT Analysis 12.4.4. Financial Overview 12.4.5. Strategic Overview 12.5. Parker Hannifin 12.5.1. Company Overview 12.5.2. Product Portfolio 12.5.3. SWOT Analysis 12.5.4. Financial Overview 12.5.5. Strategic Overview 12.6. Rad Source Technologies 12.6.1. Company Overview 12.6.2. Product Portfolio 12.6.3. SWOT Analysis 12.6.4. Financial Overview 12.6.5. Strategic Overview 12.7. Sartorius AG 12.7.1. Company Overview 12.7.2. Product Portfolio 12.7.3. SWOT Analysis 12.7.4. Financial Overview 12.7.5. Strategic Overview 12.8. SGS S.A. 12.8.1. Company Overview 12.8.2. Product Portfolio 12.8.3. SWOT Analysis 12.8.4. Financial Overview 12.8.5. Strategic Overview 12.9. Texcell, Inc. 12.9.1. Company Overview 12.9.2. Product Portfolio 12.9.3. SWOT Analysis 12.9.4. Financial Overview 12.9.5. Strategic Overview 12.10. Viral Inactivated Plasma Systems SA 12.10.1. Company Overview 12.10.2. Product Portfolio 12.10.3. SWOT Analysis 12.10.4. Financial Overview 12.10.5. Strategic Overview 13. Pre and Post COVID-19 Impact 13.1. Positive influence on the healthcare industry 13.2. The financial disruption of the manufacturing sector 13.3. Impact of COVID-19 on emerging companies 13.4. Significant mandates in the healthcare regulations initiated by administrations 13.5. The overall economic slowdown of the developing and developed nations 14. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics